GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 112 filers reported holding GENOMIC HEALTH INC in Q4 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,512,000 | +6.6% | 131,935 | 0.0% | 0.98% | +14.8% |
| Q3 2017 | $4,234,000 | -1.4% | 131,935 | 0.0% | 0.85% | -4.6% |
| Q2 2017 | $4,294,000 | +3.3% | 131,935 | 0.0% | 0.89% | -0.8% |
| Q1 2017 | $4,155,000 | +7.1% | 131,935 | 0.0% | 0.90% | +4.2% |
| Q4 2016 | $3,878,000 | +1.6% | 131,935 | 0.0% | 0.86% | +2.5% |
| Q3 2016 | $3,816,000 | +11.7% | 131,935 | 0.0% | 0.84% | +12.8% |
| Q2 2016 | $3,416,000 | +4.5% | 131,935 | 0.0% | 0.74% | +8.8% |
| Q1 2016 | $3,268,000 | -29.6% | 131,935 | 0.0% | 0.68% | -26.6% |
| Q4 2015 | $4,644,000 | +66.3% | 131,935 | 0.0% | 0.93% | +70.6% |
| Q3 2015 | $2,792,000 | -1.4% | 131,935 | +29.4% | 0.55% | +8.7% |
| Q2 2015 | $2,833,000 | -9.0% | 101,935 | 0.0% | 0.50% | -8.2% |
| Q1 2015 | $3,114,000 | +35.4% | 101,935 | +41.7% | 0.55% | +26.9% |
| Q4 2014 | $2,300,000 | +101.9% | 71,935 | +98.8% | 0.43% | +83.1% |
| Q3 2014 | $1,139,000 | – | 36,179 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |